In our study, we detected homozygous and heterozygous deletions of CDKN2A and the amplification of MDM2 and copy number gain of PPM1D, which shows that these genes can be involved in the initiation/progression of neuroblastoma through the inactivation of TP53. The gene discussed is TP53; the disease is neuroblastoma.